| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.66B | 219.72B | 197.00B | 174.90B | 178.33B | 156.29B |
| Gross Profit | 26.67B | 30.26B | 25.69B | 22.92B | 25.08B | 25.77B |
| EBITDA | 13.16B | 14.52B | 13.29B | 9.71B | 14.00B | 15.82B |
| Net Income | 4.78B | 5.60B | 4.80B | 1.60B | 5.49B | 7.51B |
Balance Sheet | ||||||
| Total Assets | 195.82B | 222.43B | 196.63B | 182.89B | 191.89B | 176.44B |
| Cash, Cash Equivalents and Short-Term Investments | 20.77B | 21.54B | 18.76B | 21.47B | 26.99B | 26.69B |
| Total Debt | 54.27B | 60.27B | 54.65B | 56.41B | 73.02B | 62.59B |
| Total Liabilities | 127.18B | 142.48B | 126.32B | 116.54B | 128.84B | 119.10B |
| Stockholders Equity | 68.06B | 79.26B | 69.70B | 65.75B | 62.52B | 56.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.03B | 463.00M | 11.77B | -4.56B | -7.59B |
| Operating Cash Flow | 0.00 | 2.42B | 7.00B | 15.21B | 226.00M | -3.33B |
| Investing Cash Flow | 0.00 | -3.22B | -4.71B | -2.62B | -7.04B | -3.26B |
| Financing Cash Flow | 0.00 | 3.34B | -4.80B | -19.28B | 5.90B | 5.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥604.84B | 8.32 | 5.02% | 2.12% | 9.83% | 130.42% | |
68 Neutral | ¥2.53T | 13.63 | 5.18% | 1.98% | 9.30% | 981.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥74.09B | 14.12 | ― | 2.98% | 11.53% | 17.06% | |
59 Neutral | ¥125.35B | 11.06 | 11.58% | 1.62% | 4.90% | -24.31% | |
58 Neutral | ¥638.86B | 15.50 | 3.12% | 2.83% | -6.02% | 19.06% | |
56 Neutral | ¥37.65B | 17.99 | ― | 9.18% | -28.55% | ― |